Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.3361
+0.0097 (2.97%)
At close: Jan 16, 2026, 4:00 PM EST
0.3417
+0.0056 (1.67%)
After-hours: Jan 16, 2026, 7:42 PM EST
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $66.78 million as of January 16, 2026. Its market cap has decreased by -62.96% in one year.
Market Cap
66.78M
Enterprise Value
73.27M
1-Year Change
-62.96%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $66.78M, a decrease of -85.05%. That is a compound annual growth rate of -37.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 66.78M | 1.51% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |